Abstract
In a case study of ten fertile women receiving a single intrauterine instillation of a suspension of Quinacrine, the six patients who did not have a hysterectomy 5 to 6 days later were found to have non-patent tubes when tested at least three weeks post-instillation. Five of these patients were using oral contraception prior to, during, and after treatment. Of the remaining four patients who underwent surgery within one week of instillation, three were found to have lesions suggesting tubal inflammation; none of these patients were using any kind of contraception.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call